ATAI THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 23 Sept 2025)
What this means for you
Not registered yet, but its 25 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98195504
- Mark type
- Stylized text
- Filed
- 25 Sept 2023
- Published for opposition
- 13 Aug 2024
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research; pharmaceutical, clinical trial and medical software testing; authentication in the field of pharmaceuticals, biotechnology and medical software; quality control for others; medical and pharmacological research services; medical laboratory services; scientific investigations for medical purposes; design and development of medical diagnostic apparatus; provision of information and data relating to medical and veterinary research and development; research and development in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; information relating to medical and scientific research in the fields of pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; providing of online non-downloadable computer software for accessing, managing, updating and displaying electronic databases, in particular in the fields of health, pharmacy, biotechnology, food science, food technology, agriculture and veterinary medicine; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; consultancy in the field of pharmaceutical research; providing information about the results of clinical trials for pharmaceutical products; pharmaceutical product evaluation; biological research, clinical research in the nature of conducting clinical trials for others and medical research; biomedical research services; testing of pharmaceuticals; basic clinical research in the field of pharmaceuticals; medical research; inspection of pharmaceuticals; consultancy relating to biotechnology research; biology research consultancy; biochemistry research consultancy; chemical research and analysis services; scientific research including preparation of reports in the biotechnology field for research purposes; scientific research in the field of genetic engineering; providing online non-downloadable computer software for monitoring and managing neurological and psychiatric diseases and communicating information on neurological and psychiatric diseases; consulting services in the field of pharmaceutical research and development, technical advice for others regarding research and development of pharmaceutical preparations, and scientific testing research and development in the field of pharmaceutical preparations; design and development of computer software
Owner
- Atai Therapeutics, Inc., Encinitas, CA, US
- Atai Therapeutics, Inc., Encinitas, CA, US
Prior registrations
Prosecution history
- 23 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Sept 2025 — SOU EXTENSION 2 GRANTED
- 23 Sept 2025 — SOU EXTENSION 2 FILED
- 23 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2025 — SOU EXTENSION 1 GRANTED
- 18 Feb 2025 — SOU EXTENSION 1 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Aug 2024 — PUBLISHED FOR OPPOSITION
- 24 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE